NasdaqCM - Nasdaq Real Time Price USD
Cardio Diagnostics Holdings, Inc. (CDIO)
4.7650
+0.2450
+(5.42%)
At close: June 6 at 4:00:00 PM EDT
4.5300
-0.23
(-4.93%)
After hours: June 6 at 7:49:31 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 131.31k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
DOGAN MEESHANTHINI Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
DOGAN TIMUR Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
DOGAN TIMUR Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
PHILIBERT ROBERT Officer and Director | Purchase at price 0.28 - 0.29 per share. | Indirect | 9,763 | Sep 6, 2024 |
LEVY ODED Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
INTRATER JAMES Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
BURTON PAUL FREDERICK Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 2.18 per share. | Direct | 1,999 | Jan 31, 2024 |
SIM BRANDON Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
LEVY ODED Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
LEVY ODED Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 16,499 | Dec 29, 2023 |
INTRATER JAMES Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 0.30 per share. | Direct | 2,000 | Oct 31, 2023 |
SIM BRANDON Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
LEVY ODED Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
LEVY ODED Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 0.34 - 1.21 per share. | Direct | 18,500 | Sep 29, 2023 |
INTRATER JAMES Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.54 - 0.56 per share. | Indirect | 9,964 | Aug 31, 2023 |
DOGAN TIMUR Chief Technology Officer | Purchase at price 0.54 - 0.56 per share. | Direct | 9,964 | Aug 31, 2023 |
PHILIBERT ROBERT Officer, Director and Beneficial Owner | Purchase at price 0.57 - 0.60 per share. | Indirect | 20,395 | Aug 28, 2023 |
SIM BRANDON Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 25,000 | Jun 30, 2023 |
LAU STANLEY K Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 34,999 | Jun 30, 2023 |
Related Tickers
SPRC SciSparc Ltd.
0.3120
-1.89%
DRMA Dermata Therapeutics, Inc.
0.7451
+5.84%
ELEV Elevation Oncology, Inc.
0.3199
+4.85%
ZVSA ZyVersa Therapeutics, Inc.
0.6549
+1.50%
PXMD PaxMedica, Inc.
0.0001
0.00%
ENSC Ensysce Biosciences, Inc.
2.3800
+1.71%
BDRX Biodexa Pharmaceuticals Plc
1.1500
0.00%
INAB IN8bio, Inc.
4.1700
+15.74%
VRAX Virax Biolabs Group Limited
0.9785
+0.77%
CERO CERo Therapeutics Holdings, Inc.
0.4545
+6.19%